高级检索
当前位置: 首页 > 详情页

Assessing the impact of comorbidities on disease severity in COVID-19 patients requires consideration of age

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Kunming Med Univ, Affiliated Hosp 1, Dept Infect Dis, 100 Renmin West Rd, Kunming 650000, Yunnan, Peoples R China [2]Wuhan Univ, Zhongnan Hosp, Res Ctr Digest Dis, Dept Gen Surg, Wuhan, Hubei, Peoples R China
出处:
ISSN:

关键词: CLINICAL CHARACTERISTICS RISK-FACTORS HOSPITALIZED-PATIENTS WUHAN CHINA

摘要:
Older age and comorbidities are risk factors for increased coronavirus disease 2019 (COVID-19) severity, but few studies have explored their interaction. This study aimed to assess the actual impacts of these factors on disease severity in COVID-19. The enrolled COVID-19 patients were divided into 4 age subgroups (<= 44, 45-59, 60-74, and >= 75 years). Logistic regression analysis was conducted to determine the association between comorbidities and disease severity; Kappa consistency test was implemented to verify the study results. Of the 1663 patients with COVID-19, 287 had severe disease. The disease severity was correlated with the age-adjusted Charlson Comorbidity Index in each age group. In the 4 subgroups, the odds ratio of age-adjusted Charlson Comorbidity Index declined with age. After removing age interference, diabetes and cardio-cerebrovascular diseases were the main risk factors for severe disease in patients aged <75 years, whereas only chronic lung disease was associated with disease severity in patients aged >= 75 years. When comorbidities alone were used to predict disease severity, only the predictions were consistent with real outcomes in patients aged >= 75 years, compared with the predictions of high-risk comorbidities mentioned in World Health Organization and Chinese guidelines (Kappa 0.106, P < .05). Although older age and comorbidities were risk factors for severe COVID-19, their effects on disease severity varied across age groups. Additionally, comorbidities had a greater impact on COVID-19 severity in younger patients.

基金:

基金编号: 2023535D14

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2026]版:
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
JCR分区:
出版当年[2025]版:
最新[2023]版:
Q2 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2025版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Kunming Med Univ, Affiliated Hosp 1, Dept Infect Dis, 100 Renmin West Rd, Kunming 650000, Yunnan, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:59206 今日访问量:0 总访问量:1886 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)